| Intrinsic Valuation of: RPRX | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 2 | Market Cap | $20B | |||||
| 2021 | - | - (-) | P/E Ratio | 15 | Total Asset | $18B | |||||
| 2022 | $2B | - (-) | Net Income | $859M | Total Debt | $7B | |||||
| 2023 | $2B | 6.3% (8.7%) | EBITDA | $2B | Total Liab | $8B | |||||
| 2024 | $3B | 39.4% (32.4%) | Opr Margin | 0.57 | Debt/Equity | 0.64 | |||||
| 2025 | $3B | -7.3% (-3.6%) | PreTax Margin | 47.13 | BV/Share | 16 | |||||
| 5Y Average FCF | $2B | 12.8% (12.5%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (12.8%) | ||||||||||
| 2026 | $3B | MBG Intrinsic Value | $22 | ||||||||
| 2027 | $4B | ||||||||||
| 2028 | $4B | ||||||||||
| 2029 | $4B | ||||||||||
| 2030 | $5B | ||||||||||
| 2031 | $6B | ||||||||||
| Terminal Value | $118B | Net Worth/Share | $25 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $97B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $929M | $216 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $7B | WACC | 7.3% | 187 | 203 | 221 | 244 | 272 | |||
| Equity Value | $91B | 7.4% | 186 | 201 | 219 | 241 | 269 | ||||
| Shares Outstanding | 421,371,008 | 7.4% | 184 | 199 | 216 | 238 | 265 | ||||
| 7.9% | 168 | 180 | 194 | 211 | 232 | ||||||
| DCF Intrinsic Value | $216 | 8.4% | 154 | 164 | 176 | 190 | 206 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||